Skip to main content

Sera Prognostics, Inc.

SERA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001534969

In the last 90 days, Sera Prognostics, Inc. insiders filed 0 open-market purchases and 5 sales; 47 institutions reported holding it in 13F filings for Q2 2026, worth $31.0M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Sera Prognostics, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of SERA: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders45230−13
Shares9.66M17.2K8.66M−990.3K (−10.3%)
Value$36.6M$114.0K$14.2M−$22.3M (−61.1%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (6)

Institutions that held Sera Prognostics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to SERA in Q2 2022
InstitutionSharesValue% of portfolio
Wells Fargo & Company303,732$498.0K0.00%
Renaissance Technologies LLC108,974$179.0K0.00%
Commonwealth Equity Services, LLC71,594$117.0K0.00%
Ergoteles LLC24,400$40.0K0.00%
Sterling Investment Advisors, Ltd.1,100$2.00K0.00%
Credit Suisse AG4$00.00%

Sold out (19)

Institutions that held Sera Prognostics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (2)

Institutions that held Sera Prognostics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SERA in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Lesa Sroufe & Co16,506$111.0K
Amalgamated Financial Corp.699$3.00K